scispace - formally typeset
I

Ivan Topolsky

Researcher at Swiss Institute of Bioinformatics

Publications -  14
Citations -  339

Ivan Topolsky is an academic researcher from Swiss Institute of Bioinformatics. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 7, co-authored 9 publications receiving 162 citations. Previous affiliations of Ivan Topolsky include ETH Zurich & University of Basel.

Papers
More filters
Posted ContentDOI

Detection of SARS-CoV-2 variants in Switzerland by genomic analysis of wastewater samples

Katharina Jahn, +25 more
- 09 Jan 2021 - 
TL;DR: In this paper, the authors report a genomic analysis of SARS-CoV-2 in 48 raw wastewater samples collected from three wastewater treatment plants in Switzerland between July 9 and December 21, 2020.
Journal ArticleDOI

The SIB Swiss Institute of bioinformatics' resources: Focus on curated databases

Lisandra Aguilar Bultet, +676 more
- 01 Jan 2016 - 
TL;DR: An overview of S IB's resources and competence areas is provided, with a strong focus on curated databases and SIB's most popular and widely used resources.
Journal ArticleDOI

Early detection and surveillance of SARS-CoV-2 genomic variants in wastewater using COJAC

Katharina Jahn, +23 more
- 18 Jul 2022 - 
TL;DR: In this paper , the authors used genomic sequencing of 122 wastewater samples from three locations in Switzerland to monitor the local spread of B.1.7 (Alpha), B.351 (Beta) and P.1 (Gamma) variants of SARS-CoV-2 at a population level.
Journal ArticleDOI

V-pipe: a computational pipeline for assessing viral genetic diversity from high-throughput data.

Susana Posada-Cespedes, +10 more
- 20 Jan 2021 - 
TL;DR: V-pipe as mentioned in this paper is a bioinformatics pipeline combining various state-of-the-art statistical models and computational tools for automated end-to-end analyses of raw sequencing reads.
Journal ArticleDOI

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland.

Chaoran Chen, +51 more
- 09 Aug 2021 - 
TL;DR: This study estimates the transmission fitness advantage and the effective reproductive number of B.1.1-CoV-2 variant of Concern in Switzerland and quantifies the variant’s transmission Fitness advantage on a national and a regional scale.